Research / CRNC / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-25-053372 General Corporate
Debt relative to revenue 5th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
79.31% · OPTIONAL · VALID
Capex intensity 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
5.70% · OPTIONAL · VALID
Operating cash generation 90th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
24.30% · OPTIONAL · VALID
Revenue growth 11th Own-history percentile · N=19
Evidence method Yoy · gp.fundamentals.revenue
-24.05% · CORE · VALID
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
0.44% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
72.74% · CORE · VALID
Operating margin 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-0.91% · CORE · VALID
R&D intensity 65th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
38.83% · OPTIONAL · VALID
SBC intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
10.86% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 27 states Self-history eligible
Sep 30, 2021 0/8 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/8 normalized Level 3 Jun 30, 2022 7/8 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 8/8 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/9 normalized Level 3 Jun 30, 2024 8/9 normalized Level 3 Sep 30, 2024 8/9 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/9 normalized Level 3 Jun 30, 2025 8/9 normalized Level 3 Sep 30, 2025 8/9 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 9/9 normalized Level 3 Jun 30, 2026 9/9 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 319.47%
Current 79.31%
Delta -240.15% Capex Intensity Decreased
Previous 12.29%
Current 5.70%
Delta -6.59% Cash Generation Decreased
Previous 38.08%
Current 24.30%
Delta -13.79% Growth Decreased
Previous -11.77%
Current -24.05%
Delta -12.28% Inventory Pressure Decreased
Previous 3.05%
Current 0.44%
Delta -2.62% Margin Decreased
Previous 73.73%
Current 72.74%
Delta -1.00% Profitability Increased
Previous -1.52%
Current -0.91%
Delta 0.61% R And D Intensity Decreased
Previous 43.63%
Current 38.83%
Delta -4.80% Sbc Intensity Increased
Previous 10.20%
Current 10.86%
Delta 0.67% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.